Hanne Leth Hillman
Presidente presso The Danish Investor Relations Society
Profilo
Hanne Leth Hillman is currently the Co-Chairman at The Danish Investor Relations Society and the Chief Financial Officer at Nanovi Radiotherapy A.
Previously, she held positions such as VP, Director-Investor Relations & Capital Market at NTG Nordic Transport Group A in 2009-2010, Analyst at Gudme Raaschou Bank A in 2004, and Senior VP-Investor Relations & Communications at Zealand Pharma A in 2015-2016.
Ms. Hillman obtained an MBA from the University of Aarhus.
Posizioni attive di Hanne Leth Hillman
| Società | Posizione | Inizio |
|---|---|---|
| The Danish Investor Relations Society | Presidente | - |
Nanovi Radiotherapy A/S
 Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Direttore Finanziario/CFO | 01/05/2017 |
Precedenti posizioni note di Hanne Leth Hillman
| Società | Posizione | Fine |
|---|---|---|
| BRAIN+ A/S | Direttore Finanziario/CFO | 01/01/2024 |
| ZEALAND PHARMA A/S | Contatto Relazioni con gli Investitori | 01/10/2016 |
| Gudme Raaschou Bank A/S | Analyst-Equity | 05/11/2004 |
| NTG NORDIC TRANSPORT GROUP A/S | Contatto Relazioni con gli Investitori | - |
Formazione di Hanne Leth Hillman
| University of Aarhus | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| ZEALAND PHARMA A/S | Health Technology |
| BRAIN+ A/S | Technology Services |
| Aziende private | 3 |
|---|---|
| Gudme Raaschou Bank A/S | Finance |
| The Danish Investor Relations Society | |
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Hanne Leth Hillman